Conference Coverage EHA 2023 – Focus on Multiple Myeloma (Global)

The latest therapeutic developments in multiple myeloma – how will they change our approach to treatment patterns?

June 22, 2023
Purchase Report

Faculty Chair

Rafael Fonseca, MD

Mayo Clinic, Phoenix, AZ, USA

Faculty Members

Irene Ghobrial, MD
Dana-Farber Cancer Institute, Boston, MA, USA

Hermann Einsele, MD, FRCP
University Hospital Würzburg, Germany

Keith Stewart, MB, ChB
Princess Margaret Cancer Centre, Toronto, ON, Canada

Gareth Morgan, MD, PhD, FRCP, FRCPath
NYU Langone Health, New York, NY, USA

Xavier Leleu, MD, PhD
Poitiers University Hospital, Poitiers, France

Niels van de Donk, MD, PhD
Amsterdam UMC, Amsterdam, the Netherlands

 

Agenda

Download the meeting agenda

View Agenda

Sample Report

Start discovering the insights

View Report

REPORT TOPICS

  • Treatment in Transplant-Eligible and Smoldering Multiple Myeloma
  • NDMM: Transplant-Ineligible Multiple Myeloma
  • Relapsed/Refractory Multiple Myeloma: Small Molecules
  • Relapsed/Refractory Multiple Myeloma: Antibodies and Bispecifics
  • Relapsed/Refractory Multiple Myeloma: CAR T

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.